Magle Chemoswed Holding Ab

MAGLE · Nasdaq Stockholm · Healthcare

0.48SEK −2.0%last day

Price as of 2 October 2026

The price over the past year, with dividends: −97.4%

Performance

1 month

+56.1%

1 year

−97.4%

3 years, per year

−75.2%

5 years, per year

−57.5%

Largest fall, 3 years

−99.3%

Below the peak now

−98.9%

Volatility, 1 year

208.4%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

0.0

Dividend yield

0.0%

Return on equity

−65.2%

Net margin

−58.4%

Market value

1 m USD

Quality, value and trend

Where Magle Chemoswed Holding stands against every Nordic stock today. 100 is best.

Quality12

Profitability and a sound balance sheet over time. Better than 12% of Nordic stocks.

Trend1

The price development over the past year. Better than 1% of Nordic stocks.

About Magle Chemoswed Holding

Magle Chemoswed Holding Ab is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 150 employees.

Magle Chemoswed Holding AB (publ) engages in researching, developing, and manufacturing in the areas of medicinal chemistry and pharmaceutical technology in Sweden, Switzerland, rest of Europe, the United States, Brazil, and internationally. It offers degradable starch microsphere and dextran products; and active pharmaceutical ingredients, as well as engages in the research, development, manufacture, market, and sale of diagnostics products to hospitals, clinics, and pharmacies; and contract development and manufacturing organization activities.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis